Finland, Some of the toughest legislation in Europe
What do we know about Finland? That it belongs to the Nordic countries; that it gets very cold; that its landscapes are impressive; that it’s the best place to see the Northern Lights; that Santa…
Iberian Peninsula express shipping
0€ Orders over 60€
*6€ orders under 59€
East, West, South Europe express shipping
0€ Orders over 150€
*18€ orders under 149€
North Europe express shipping
0€ Orders over 160€
*20€ orders under 159€
Ireland, Norway, UK normal shipping
0€ Orders over 60€
*6€ orders under 59€
Rest of the world normal shipping
0€ Orders over 180€
*25€ orders under 179€
Shipping costs can be confirmed in your shopping cart.
For additional shipping methods, please reach out through info@kannabia.com.
*Website protected by SSL.
**Not available in all regions.
*Your coupon will be sent via email.
*Should you have any question, comment or feedback, please do not hesitate to contact us.
A group of researchers from the University of Parma, University of Naples “Federico II”, and other Italian institutions presented a retrospective case series analysis of all chronic pain patients treated with oral or vaporized cannabis in six centers during the initial year following the approval of the new Italian law (December 2015 to November 2016). They evaluated routes of administration, types of cannabis products utilized, dosing, and effectiveness and safety of the treatment.
As only one of the six centres has extensively used cannabinoids for intractable chronic pain (614 patients of 659), only the population from Azienda Ospedaliero Universitaria Pisana (Pisa) was considered. Cannabis tea was the primary mode of delivery, and in almost all cases, it was used in association with other pain treatments. At initial follow-up, 76.2% of patients continued the treatment, and less than 15% stopped the treatment due to side effects. Researchers wrote “that the treatment seems to be effective and safe.”
Source: IACM